Mestinon (Pyridostigmine) for Myasthenia Gravis | MGteam

Connect with others who understand.

sign up Log in
About MGteam
Powered By

Mestinon is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat myasthenia gravis. Mestinon may also be referred to by its drug name, pyridostigmine.
Mestinon is in a class of drugs called cholinesterase inhibitors. It is believed to work by breaking down acetylcholine to improve the communication between nerves and muscles. This can help reduce muscle weakness.

How do I take it?
Mestinon is available as a tablet, a syrup, and a time-release formula called Mestinon Timespan. It is taken once or twice daily. Your doctor will recommend the ideal dose for you, depending on your symptoms.

Side effects
Common side effects of Mestinon include stomach pain, nausea, vomiting, diarrhea, muscle cramps, sweating, increased salivation, rash, blurry vision, and coughing.

Rare but serious side effects include loss of movement or extremely weak muscles, shallow breathing, slurred speech, trouble with vision, allergic reactions, and worsening symptoms of myasthenia gravis.

For more information about this treatment, visit:

Mestinon — — MedlinePlus

Pyridostigmine — MedlinePlus

Continue with Facebook
Continue with Google
Lock Icon Your privacy is our priority. By continuing, you accept our Terms of use, and our Health Data and Privacy policies.
Already a Member? Log in